Study Title

Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer

Study Details

Description:

This clinical trial will evaluate the safety of Cabazitaxel in combination with 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer.

Sponsor:

Peter MacCallum Cancer Centre

Contacts:

Gaurav Sharma

gaurav.sharma@petermac.org

03 85596830

Dr Louise Kostos

louise.kostos@petermac.org

Government Study Link:

NCT05340374 - Click here to see study on

ClinicalTrials.gov

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468